Polymorphisms of the NER pathway genes, ERCC1 and XPD are associated with esophageal adenocarcinoma risk

Cancer Causes and Control

Volumn 19, Issue 10, 2008, Pages 1077-1083

  Tse, Darren ^a   Zhai, Rihong ^b   Zhou, Wei ^b   Heist, Rebecca S ^b,c   Asomaning, Kofi ^b   Su, Li ^b   Lynch, Thomas J ^c   Wain, John C ^d   Christiani, David C ^b,c   Liu, Geoffrey ^a,b,c  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

Author keywords

Adenocarcinoma; DNA repair; Esophageal cancer; Nucleotide excision pathway; Polymorphism

Indexed keywords

DNA (APURINIC OR APYRIMIDINIC SITE) LYASE; EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 1; XERODERMA PIGMENTOSUM GROUP D PROTEIN;

ADULT; AGED; ALLELE; ARTICLE; BLOOD SAMPLING; CANCER RISK; CARCINOGENESIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA EXTRACTION; ESOPHAGEAL ADENOCARCINOMA; EXCISION REPAIR; FEMALE; GENETIC ASSOCIATION; GENETIC MODEL; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ALLELES; CASE-CONTROL STUDIES; DNA REPAIR; DNA-BINDING PROTEINS; ENDONUCLEASES; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; INTERVIEWS AS TOPIC; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; QUESTIONNAIRES; RISK FACTORS; XERODERMA PIGMENTOSUM GROUP D PROTEIN; YOUNG ADULT;

EID: 55849110863     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-008-9171-4     Document Type: Article

References (45)

1. SS Devesa WJ Blot JF Fraumeni Jr 1998 Changing patterns in the incidence of esophageal and gastric carcinoma in the United States Cancer 83 10 2049 2053
2. M Younes DE Henson A Ertan CC Miller 2002 Incidence and survival trends of esophageal carcinoma in the United States: racial and gender differences by histological type Scand J Gastroenterol 37 12 1359 1365
3. DH Ilson 2003 Oesophageal cancer: new developments in systemic therapy Cancer Treat Rev 29 6 525 532
4. RS Holmes TL Vaughan 2007 Epidemiology and pathogenesis of esophageal cancer Semin Radiat Oncol 17 1 2 9
5. JR Siewert K Ott 2007 Are squamous and adenocarcinomas of the esophagus the same disease? Semin Radiat Oncol 17 1 38 44
6. AJ Cameron 1997 Epidemiology of columnar-lined esophagus and adenocarcinoma Gastroenterol Clin North Am 26 3 487 494
7. AG Casson Z Zheng SC Evans PJ Veugelers GA Porter DL Guernsey 2005 Polymorphisms in DNA repair genes in the molecular pathogenesis of esophageal (Barrett) adenocarcinoma Carcinogenesis 26 9 1536 1541
8. DJ Drewitz RE Sampliner HS Garewal 1997 The incidence of adenocarcinoma in Barrett's esophagus: a prospective study of 170 patients followed 4.8 years Am J Gastroenterol 92 2 212 215
9. DA Katzka AK Rustgi 2000 Gastroesophageal reflux disease and Barrett's esophagus Med Clin North Am 84 5 1137 1161
10. R Naidoo R Chetty 1999 DNA repair gene status in oesophageal cancer Mol Pathol 52 3 125 130
11. P Sharma TG Morales A Bhattacharyya HS Garewal RE Sampliner 1997 Dysplasia in short-segment Barrett's esophagus: a prospective 3-year follow-up Am J Gastroenterol 92 11 2012 2016
12. JM Lee YC Lee SY Yang 2001 Genetic polymorphisms of XRCC1 and risk of the esophageal cancer Int J Cancer 95 4 240 246
13. S Benhamou J Tuimala C Bouchardy P Dayer A Sarasin A Hirvonen 2004 DNA repair gene XRCC2 and XRCC3 polymorphisms and susceptibility to cancers of the upper aerodigestive tract Int J Cancer 112 5 901 904
14. JJ Hu MC Hall L Grossman 2004 Deficient nucleotide excision repair capacity enhances human prostate cancer risk Cancer Res 64 3 1197 1201
15. C Li Z Hu Z Liu 2006 Polymorphisms in the DNA repair genes XPC, XPD, and XPG and risk of cutaneous melanoma: a case-control analysis Cancer Epidemiol Biomarkers Prev 15 12 2526 2532
16. RM Lunn KJ Helzlsouer R Parshad 2000 XPD polymorphisms: effects on DNA repair proficiency Carcinogenesis 21 4 551 555
17. JM Ramos A Ruiz R Colen ID Lopez L Grossman JL Matta 2004 DNA repair and breast carcinoma susceptibility in women Cancer 100 7 1352 1357
18. H Shen MR Spitz Y Qiao 2003 Smoking, DNA repair capacity and risk of nonsmall cell lung cancer Int J Cancer 107 1 84 88
19. Q Shi LE Wang ML Bondy A Brewster SE Singletary Q Wei 2004 Reduced DNA repair of benzo[a]pyrene diol epoxide-induced adducts and common XPD polymorphisms in breast cancer patients Carcinogenesis 25 9 1695 1700
20. MR Spitz X Wu Y Wang 2001 Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients Cancer Res 61 4 1354 1357
21. Q Wei L Cheng CI Amos 2000 Repair of tobacco carcinogen-induced DNA adducts and lung cancer risk: a molecular epidemiologic study J Natl Cancer Inst 92 21 1764 1772
22. Q Wei JE Lee JE Gershenwald 2003 Repair of UV light-induced DNA damage and risk of cutaneous malignant melanoma J Natl Cancer Inst 95 4 308 315
23. EJ Duell JK Wiencke TJ Cheng 2000 Polymorphisms in the DNA repair genes XRCC1 and ERCC2 and biomarkers of DNA damage in human blood mononuclear cells Carcinogenesis 21 5 965 971
24. Y Wang MR Spitz Y Zhu Q Dong S Shete X Wu 2003 From genotype to phenotype: correlating XRCC1 polymorphisms with mutagen sensitivity DNA Repair (Amst) 2 8 901 908
25. S Benhamou A Sarasin 2005 ERCC2/XPD gene polymorphisms and lung cancer: a HuGE review Am J Epidemiol 161 1 1 14
26. W Ye R Kumar G Bacova J Lagergren K Hemminki O Nyren 2006 The XPD 751Gln allele is associated with an increased risk for esophageal adenocarcinoma: a population-based case-control study in Sweden Carcinogenesis 27 9 1835 1841
27. G Liu W Zhou BY Yeap 2007 XRCC1 and XPD polymorphisms and esophageal adenocarcinoma risk Carcinogenesis 28 6 1254 1258
28. EL Goode CM Ulrich JD Potter 2002 Polymorphisms in DNA repair genes and associations with cancer risk Cancer Epidemiol Biomarkers Prev 11 12 1513 1530
29. B Hao H Wang K Zhou 2004 Identification of genetic variants in base excision repair pathway and their associations with risk of esophageal squamous cell carcinoma Cancer Res 64 12 4378 4384
30. JM Weiss EL Goode WC Ladiges CM Ulrich 2005 Polymorphic variation in hOGG1 and risk of cancer: a review of the functional and epidemiologic literature Mol Carcinog 42 3 127 141
31. D Xing J Qi X Miao W Lu W Tan D Lin 2002 Polymorphisms of DNA repair genes XRCC1 and XPD and their associations with risk of esophageal squamous cell carcinoma in a Chinese population Int J Cancer 100 5 600 605
32. DY Xing W Tan N Song DX Lin 2001 Ser326Cys polymorphism in hOGG1 gene and risk of esophageal cancer in a Chinese population Int J Cancer 95 3 140 143
33. S Chen D Tang K Xue 2002 DNA repair gene XRCC1 and XPD polymorphisms and risk of lung cancer in a Chinese population Carcinogenesis 23 8 1321 1325
34. Z Hu Y Wang X Wang 2005 DNA repair gene XPC genotypes/haplotypes and risk of lung cancer in a Chinese population Int J Cancer 115 3 478 483
35. Z Hu L Xu M Shao 2006 Polymorphisms in the two helicases ERCC2/XPD and ERCC3/XPB of the transcription factor IIH complex and risk of lung cancer: a case-control analysis in a Chinese population Cancer Epidemiol Biomarkers Prev 15 7 1336 1340
36. P Chacko B Rajan T Joseph BS Mathew MR Pillai 2005 Polymorphisms in DNA repair gene XRCC1 and increased genetic susceptibility to breast cancer Breast Cancer Res Treat 89 1 15 21
37. S Benhamou A Sarasin 2002 ERCC2/XPD gene polymorphisms and cancer risk Mutagenesis 17 6 463 469
38. KM Lee JY Choi C Kang 2005 Genetic polymorphisms of selected DNA repair genes, estrogen and progesterone receptor status, and breast cancer risk Clin Cancer Res 11 12 4620 4626
39. J Shen M Desai M Agrawal 2006 Polymorphisms in nucleotide excision repair genes and DNA repair capacity phenotype in sisters discordant for breast cancer Cancer Epidemiol Biomarkers Prev 15 9 1614 1619
40. P Chen J Wiencke K Aldape 2000 Association of an ERCC1 polymorphism with adult-onset glioma Cancer Epidemiol Biomarkers Prev 9 8 843 847
41. W Zhou G Liu S Park 2005 Gene-smoking interaction associations for the ERCC1 polymorphisms in the risk of lung cancer Cancer Epidemiol Biomarkers Prev 14 2 491 496
42. DJ Park W Zhang J Stoehlmacher 2003 ERCC1 gene polymorphism as a predictor for clinical outcome in advanced colorectal cancer patients treated with platinum-based chemotherapy Clin Adv Hematol Oncol 1 3 162 166
43. J Viguier V Boige C Miquel 2005 ERCC1 codon 118 polymorphism is a predictive factor for the tumor response to oxaliplatin/5-fluorouracil combination chemotherapy in patients with advanced colorectal cancer Clin Cancer Res 11 17 6212 6217
44. R Suk S Gurubhagavatula S Park 2005 Polymorphisms in ERCC1 and grade 3 or 4 toxicity in non-small cell lung cancer patients Clin Cancer Res 11 4 1534 1538
45. W Zhou S Gurubhagavatula G Liu 2004 Excision repair cross-complementation group 1 polymorphism predicts overall survival in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy Clin Cancer Res 10 15 4939 4943